Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice

被引:30
作者
Deckel, AW
Volmer, P
Weiner, R
Gary, KA
Covault, J
Sasso, D
Schmerler, N
Watts, D
Yan, Z
Abeles, I
机构
[1] Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Diagnost Imaging & Therapeut, Farmington, CT 06030 USA
[3] Univ Connecticut, Ctr Hlth, Program Neurosci, Farmington, CT 06030 USA
[4] Univ Connecticut, Ctr Hlth, Hartford Hosp, Huntingtons Dis Program, Hartford, CT 06102 USA
关键词
Huntington's disease; L-arginine; nitric oxide; peroxynitrite; neurodegeneration; cerebral blood flow; diet;
D O I
10.1016/S0006-8993(00)02640-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent neuroimaging studies reported complex changes in cerebral blood how (CBF) in early-staged Huntington's disease (HD) patients. Deckel and co-workers [Deckel and Duffy, Brain Res. (in press); Deckel and Cohen, Frog. Neuro-Psychopharmacol. Biol. Psychiatry 24 (2000) 193; Deckel et al., Neurology 51 (1998) 1576; Deckel et al., J. Nucl. Med. 41 (2000) 773] suggested that these findings might be accounted for, in part, by alterations in cerebral nitric oxide (NO) and its byproduct, peroxynitrite. The current experiment tested this hypothesis by altering NO levels via manipulations of dietary L-arginine (ARG), the dietary precursor of NO, in mice transgenic for HD. Seventy-one mice were assigned at 12 weeks of age to one of three isocaloric diets that varied in their content of ARG. These diets included: (a) 0% ARG, (b) 1.2% ARG (i.e. typical mouse chow), or (c) 5% ARG. The 5% ARG diets in HD mice accelerated the time of onset of body weight loss (P<0.05) and motor impairments (P<0.05), and increased resting CBF in HD relative to control (P<0.05). Conversely, the 0% ARG diet demonstrated no loss of body weight and had no changes in CBF relative to controls. However, the 0% ARG HD group continued to show significant deficits on motor testing (P<0.05). The 1.2% ARG HD group showed reduced body weight loss, better motor functioning, and fewer changes in CBF compared to the 5% ARG HD group. Immunocytochemistry analysis found greater deposition of nitrotyrosine in the cortex, and vasculature, of HD+ mice, 58 and 1.2%>0% arginine diets. When collapsed across all conditions, CBF inversely correlated (P<0.05) both with the body weight and motor changes suggesting that changes in CBF are associated with behavioral decline in HD mice. Collectively, these findings indicate that dietary consumption of the NO precursor ARG has a measurable, but complex, effect on symptom progression in HD transgenic mice, and implicates NO in the pathophysiology of HD. (C) 2000 Elsevier Science BN. All rights reserved.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 77 条
[31]   ROLE OF NITRIC-OXIDE SYNTHASE-CONTAINING VASCULAR NERVES IN CEREBROVASODILATION ELICITED FROM CEREBELLUM [J].
IADECOLA, C ;
ZHANG, FY ;
XU, XH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (04) :R738-R746
[32]   SIN-1 REVERSES ATTENUATION OF HYPERCAPNIC CEREBROVASODILATION BY NITRIC-OXIDE SYNTHASE INHIBITORS [J].
IADECOLA, C ;
ZHANG, FY ;
XU, XH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01) :R228-R235
[33]   NITRIC-OXIDE SYNTHASE INHIBITION AND CEREBROVASCULAR REGULATION [J].
IADECOLA, C ;
PELLIGRINO, DA ;
MOSKOWITZ, MA ;
LASSEN, NA .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (02) :175-192
[34]   Bright and dark sides of nitric oxide in ischemic brain injury [J].
Iadecola, C .
TRENDS IN NEUROSCIENCES, 1997, 20 (03) :132-139
[35]   Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice [J].
Mangiarini, L ;
Sathasivam, K ;
Seller, M ;
Cozens, B ;
Harper, A ;
Hetherington, C ;
Lawton, M ;
Trottier, Y ;
Lehrach, H ;
Davies, SW ;
Bates, GP .
CELL, 1996, 87 (03) :493-506
[36]  
MAYER B, 1992, J NEUROCHEM, V59, P2024
[37]   BRAIN NITRIC-OXIDE SYNTHASE IS A BIOPTERIN-CONTAINING AND FLAVIN-CONTAINING MULTIFUNCTIONAL OXIDOREDUCTASE [J].
MAYER, B ;
JOHN, M ;
HEINZEL, B ;
WERNER, ER ;
WACHTER, H ;
SCHULTZ, G ;
BOHME, E .
FEBS LETTERS, 1991, 288 (1-2) :187-191
[38]   NITRIC-OXIDE SYNTHASE-CATALYZED ACTIVATION OF OXYGEN AND REDUCTION OF CYTOCHROMES - REACTION-MECHANISMS AND POSSIBLE PHYSIOLOGICAL IMPLICATIONS [J].
MAYER, B ;
HEINZEL, B ;
KLATT, P ;
JOHN, M ;
SCHMIDT, K ;
BOHME, E .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 :S54-S56
[39]   Inflammation of the brain in Alzheimer's disease: implications for therapy [J].
McGeer, PL ;
McGeer, EG .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (04) :409-415
[40]   PARADOXICAL FATE AND BIOLOGICAL ACTION OF PEROXYNITRITE ON HUMAN PLATELETS [J].
MORO, MA ;
DARLEYUSMAR, VM ;
GOODWIN, DA ;
READ, NG ;
ZAMORAPINO, R ;
FEELISCH, M ;
RADOMSKI, MW ;
MONCADA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6702-6706